1887

Management of autoimmune and immune-mediated skin diseases

image of Management of autoimmune and immune-mediated skin diseases
GBP
Online Access: GBP25.00 + VAT
BSAVA Library Pass Buy a pass

Abstract

This chapter covers the treatment goals, treatment strategies, specific therapeutics and pain relief for autoimmune and immune-mediated skin diseases.

Preview this chapter:
Loading full text...

Full text loading...

/content/chapter/10.22233/9781910443811.chap29

Figures

Image of 29.3
29.3 Localized epidermal atrophy, calcinosis cutis and secondary infection caused by repeated application of a topical glucocorticoid.
Image of 29.4
29.4 Calcinosis cutis on the dorsal neck that developed after glucocorticoid therapy for pemphigus foliaceus.
Image of 29.5
29.5 Epidermal atrophy and skin tearing in a cat after systemic glucocorticoid therapy.
Image of 29.6
29.6 Ear tip curling as a result of systemic glucocorticoid therapy in a cat.
Image of 29.7
29.7 Fatal thromboembolism resulting from glucocorticoid therapy.
Image of 29.9
29.9 Gingival hyperplasia resulting from long-term ciclosporin treatment.
Image of 29.10
29.10 Hirsutism resulting from long-term ciclosporin treatment.

More like this

/content/chapter/10.22233/9781910443811.chap29
dcterms_title,dcterms_description
-contentType:Journal
5
5
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error